Trademark Search in Canada

DOCANALYTICS

View On IC.GC.CA

REGISTERED

on 26 Apr 2023

Last Applicant/ Owned by

DOCTOR EVIDENCE LLC

508 12th StSanta Monica CA 90402

Serial Number

2140168 filed on 23^rd Aug 2021

Registration Number

TMA1178015 registered on 26^th Apr 2023

Registration expiry Date

23^rd Aug 2031

Correspondent Address

CLARK WILSON LLP

900 - 885 WEST GEORGIA STREETVANCOUVER

BRITISH COLUMBIA

V6C3H1

DOCANALYTICS

Trademark usage description

providing software as a service (saas) services featuring software using artificial intelligence for analyzing clinical trial data in the field of pha Read More

Classification Information

Class [042]
Providing software as a service (saas) services featuring software using artificial intelligence for analyzing clinical trial data in the field of pharmaceutical drug research and development.

Classification kind code

Mark Details

Serial Number

2140168

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 26 on 13^th Jan 2023	Approved
Submitted for opposition 27 on 13^th Jan 2023	Approval Notice Sent
Submitted for opposition 22 on 9^th Jan 2023	Search Recorded
Submitted for opposition 256 on 15^th Aug 2022	Notification of Possible Opposition Sent
Submitted for opposition 48 on 23^rd Feb 2022	Agent Changed
Submitted for opposition 257 on 14^th Oct 2021	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 14^th Oct 2021	Created
Submitted for opposition 31 on 14^th Oct 2021	Formalized
Submitted for opposition 228 on 23^rd Aug 2021	International Registration
Submitted for opposition 30 on 23^rd Aug 2021	Filed

DOCANALYTICS

Classification Information

Class [042]Providing software as a service (saas) services featuring software using artificial intelligence for analyzing clinical trial data in the field of pharmaceutical drug research and development.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [042]
Providing software as a service (saas) services featuring software using artificial intelligence for analyzing clinical trial data in the field of pharmaceutical drug research and development.